Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta
The sale is expected to close in the first quarter of 2022
Urban, semi-urban and remote corners of the country will be catered using drone delivery technology
Takes charge to lead business innovation, strategy, alliance & partnerships
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
It plans to add over 1000 employees over the next six months
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
Subscribe To Our Newsletter & Stay Updated
